Optimized Metabolomic Approach to Identify Uremic Solutes in Plasma of Stage 3–4 Chronic Kidney Disease Patients-Reference-Cited by-同舟云学术

Optimized Metabolomic Approach to Identify Uremic Solutes in Plasma of Stage 3–4 Chronic Kidney Disease Patients

Published:2013-08-02 Issue:8 Volume:8 Page:e71199
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Mutsaers Henricus A. M.,Engelke Udo F. H.,Wilmer Martijn J. G.,Wetzels Jack F. M.,Wevers Ron A.,van den Heuvel Lambertus P.,Hoenderop Joost G.,Masereeuw Rosalinde

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. Common pathophysiological mechanisms of chronic kidney disease: therapeutic perspectives;JM Lopez-Novoa;Pharmacol Ther,2010

2. Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations;HA Mutsaers;PLoS One,2011

3. Review on uremic toxins: classification, concentration, and interindividual variability;R Vanholder;Kidney Int,2003

4. Metabolite profiling identifies markers of uremia;EP Rhee;J Am Soc Nephrol,2010

5. Normal and Pathologic Concentrations of Uremic Toxins;F Duranton;J Am Soc Nephrol,2012

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How urine metabolomics can help in the follow-up of kidney transplant recipients: An untargeted metabolomics-based multiplatform study;2024-07-03

2. Altered gut mycobiome in patients with end-stage renal disease and its correlations with serum and fecal metabolomes;Journal of Translational Medicine;2024-02-25

3. A systematic review of metabolomic findings in adult and pediatric renal disease;Clinical Biochemistry;2024-01

4. Identifying disease progression in chronic kidney disease using proton magnetic resonance spectroscopy;Progress in Nuclear Magnetic Resonance Spectroscopy;2023-04

5. Using nuclear magnetic resonance urine metabolomics to develop a prediction model of early stages of renal disease in subjects with type 2 diabetes;Journal of Pharmaceutical and Biomedical Analysis;2022-09